CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-12-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,300 | $15.17 | $35K | 375,478 |
| 2016-12-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −100 | $15.82 | $2K | 375,378 |
| 2016-12-15 | Haqq Christopher Chief Medical Officer | Sale | −6,000 | $15.40 | $92K | 370,105 |
| 2016-12-07 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,600 | $17.30 | $62K | 377,778 |
| 2016-12-06 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,600 | $18.55 | $67K | 381,378 |
| 2016-11-23 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,500 | $18.40 | $46K | 386,078 |
| 2016-11-23 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,100 | $19.22 | $21K | 384,978 |
| 2016-11-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −8,400 | $18.21 | $153K | 388,578 |
| 2016-11-21 | Haqq Christopher Chief Medical Officer | Sale | −7,068 | $17.85 | $126K | 376,105 |
| 2016-11-17 | Soffer Gad Chief Operating Officer | Sale | −1,480 | $18.41 | $27K | 230,812 |
| 2016-11-16 | Gallagher Carol Giltner Director | Sale | −1,184 | $19.35 | $23K | 99,010 |
| 2016-11-16 | Clark Mitchall G. Chief R & QA Officer | Sale | −2,995 | $19.53 | $58K | 95,187 |
| 2016-11-16 | Soffer Gad Chief Operating Officer | Sale | −7,136 | $19.27 | $138K | 232,292 |
| 2016-11-15 | Ciechanover Isaac E. Chief Executive Officer | Exercise or conversion | +5,908 | 555,044 | ||
| 2016-11-15 | Ciechanover Isaac E. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −5,908 | 27,569 | ||
| 2016-11-15 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion | +2,805 | 92,128 | ||
| 2016-11-15 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion | +7,698 | 99,826 | ||
| 2016-11-15 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −2,805 | 3,739 | ||
| 2016-11-15 | MCGRATH JOHN Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −7,698 | 35,921 | ||
| 2016-11-15 | Haqq Christopher Chief Medical Officer | Exercise or conversion | +829 | 384,777 |
Page 49 of 71 · 1,403 trades